Prohance | Gadoteridol Injection Breastfeeding
Modern medicine has evolved so much so that sooner or later every breastfeeding mother needs to take it in one form or other. Medication that is present in mothers blood will transfer into her breast milk to some extent. Most drugs do so at low levels and pose no real risk to infants but then there are some exceptions. In This post will discuss whether Prohance | Gadoteridol Injection is safe in breast-feeding or not.

What is Prohance | Gadoteridol Injection used for?


Central Nervous System ProHance (Gadoteridol) Injection is indicated for use in MRI in adults and children over 2 years of age to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues. Extracranial/Extraspinal Tissues ProHance is indicated for use in MRI in adults to visualize lesions in the head and neck.

Prohance | Gadoteridol Injection while breastfeeding safe or not? Can there be any side effects for infant while using it during breastfeeding?

Prohance | Gadoteridol Injection safe for breastfeeding
As per our analysis Prohance | Gadoteridol Injection contains only one ingredient and that is Gadoteridol. We have analyzed Gadoteridol and it seems to be safe to use Gadoteridol while breastfeeding, that means usage of Prohance | Gadoteridol Injection shall be safe while breastfeeding. Below you can check more details of Gadoteridol usage in breastfeeding. We recommend you to go through provided detailed analysis as below take decision accordingly.

Statement of Manufacturer/Labeler about breastfeeding usage
Nursing Mothers It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when ProHance is administered to a nursing woman.

Prohance | Gadoteridol Injection Breastfeeding Analsys


Gadoteridol while Breastfeeding

Safe

CAS Number: 120066-54-8

Prohance | Gadoteridol Injection and breastfeeding

Gadolinium chelate.The meglumine gadopentetate is excreted into breast milk in clinically non-significant (0.02% of the maternal dose) amount and there have been no problems in infants whose mothers had received this contrast medium. It has been used in the pediatric and neonatal age. The various contrast media that are gadolinium derivatives and used for explorations with Magnetic Resonance Imaging (MRI) are considered compatible with breastfeeding because they are quickly eliminated (elimination half-life of less than 2 hours). They undergo very little metabolic changes and are virtually non-absorbable orally. They are structurally very similar to each other. Some have been shown to have no or minimal excretion into the milk. Less than 0.04% of the dose given to the mother ends just going into the milk.Due to its low oral bioavailability, intestinal absorption should be less than 1% of the dose took by the infant.The maximum dose received by the infant is considered less than 0.0004% of the maternal dose, which is much less than the dose administered to a newborn infant who undergoes a MRI scan. Most Radiology Scientific Societies agree that after an MRI scan is not necessary to temporarily stop breastfeeding. Some authors recommend avoiding the use on lactating women of some Gadolinium contrast media that would pose a high risk for developing Systemic Nephrogenic Fibrosis, especially in the neonatal period, like gadoversetamide, and gadodiamide dimeglumine, by using instead low-risk ones like gadoterate, gadoteridol and gadobutrol.


Prohance | Gadoteridol Injection Breastfeeding Analsys - 2


Gadoteridol while Breastfeeding

CAS Number: 112188-16-6

There is no published experience with gadoteridol during breastfeeding. Guidelines developed by several professional organizations state that breastfeeding need not be disrupted after a nursing mother receives a gadolinium-containing contrast medium.[1][2][3] Gadoteridol is one of the most stable gadolinium agents, theoretically making it one of the safer drugs to use during breastfeeding. However, because there is no published experience with gadoteridol during breastfeeding, other agents may be preferred, especially while nursing a newborn or preterm infant.


Is Prohance | Gadoteridol Injection safe while breastfeeding

I am nursing mother and I have already used Prohance | Gadoteridol Injection, what should I do?

As usage of Prohance | Gadoteridol Injection is mostly safe while breastfeeding hence there should not be any concern. In case of any change in behavior or health of your baby you should inform your health care provider about usage of Prohance | Gadoteridol Injection else no further action is required.


I am nursing mother and my doctor has suggested me to use Prohance | Gadoteridol Injection, is it safe?

Definitely, Prohance | Gadoteridol Injection is safe in lactation for baby. No wonder your doctor has recommended it.


If I am using Prohance | Gadoteridol Injection, will my baby need extra monitoring?

No extra baby monitoring required while mother is using Prohance | Gadoteridol Injection


Who can I talk to if I have questions about usage of Prohance | Gadoteridol Injection in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week